skip to Main Content

Switching from Statin Monotherapy to Ezetimibe/Simvastatin or Rosuvastatin Modifies the Relationships between Apolipoprotein B, LDL Cholesterol and Non-HDL Cholesterol in Patients at High Risk of Coronary Disease.

Back To Top